Enovis Insider Purchase: 3,200 Shares by Chief Legal Officer at $31.41

Rhea-AI Filing Summary

Insider purchase by Enovis executive: Tandy Bradley J, SVP and Chief Legal Officer of Enovis Corporation (ENOV), reported purchasing 3,200 shares of Enovis common stock on 08/22/2025 at a price of $31.41 per share. After the transaction, Mr. Bradley beneficially owned 43,515 shares. The Form 4 was signed via attorney-in-fact on 08/25/2025.

Positive

• Insider purchase reported: SVP and Chief Legal Officer acquired 3,200 shares at $31.41, raising beneficial ownership to 43,515 shares
• Timely disclosure: Form 4 filed and signed (via attorney-in-fact) within days of the transaction

Negative

• None.

Insights

Financial Analyst

TL;DR: An insider bought 3,200 shares at $31.41, modestly increasing insider ownership—generally a mild positive signal about executive confidence.

The purchase by the SVP and Chief Legal Officer increases his beneficial holdings to 43,515 shares. The transaction size is relatively small versus typical market-capitalization scales, so its market-moving potential is limited, but insider purchases often receive positive attention from investors as a sign of management confidence.

Corporate Governance Expert

TL;DR: Transaction is routine and properly reported; timing and use of an attorney-in-fact indicate compliant disclosure practices.

The Form 4 discloses a purchase under code "P" on 08/22/2025 and was filed with a signature by an attorney-in-fact on 08/25/2025. There is no other information about a trading plan or related parties. From a governance perspective, the filing appears complete and conforms to Section 16 reporting requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tandy Bradley J

(Last) (First) (Middle)

2711 CENTERVILLE ROAD

SUITE 400

(Street)

WILMINGTON DE 19808

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	08/22/2025		P		3,200	A	$31.41	43,515	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian P. Hanigan, attorney-in-fact	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovis (ENOV) report?

Tandy Bradley J, SVP and Chief Legal Officer, purchased 3,200 shares of Enovis common stock on 08/22/2025 at $31.41 per share.

How many Enovis shares does the reporting person own after the transaction?

Following the purchase the reporting person beneficially owned 43,515 shares according to the Form 4.

When was the Form 4 for the ENOV transaction filed and signed?

The transaction date was 08/22/2025 and the Form 4 shows a signature by an attorney-in-fact dated 08/25/2025.

What transaction code was used on the Form 4 for ENOV?

The Form 4 lists transaction code P, indicating a purchase of shares.

Does the filing disclose any derivative transactions or additional securities?

No. Table II for derivative securities contains no entries; only the non-derivative purchase is reported.